Cargando…

Real-Time Assessment of Staphylococcus aureus Biofilm Disruption by Phage-Derived Proteins

A current focus of research is the development of new tools for removing bacterial biofilms in industrial settings. Bacteriophage-encoded proteins, such as endolysins, virion-associated peptidoglycan hydrolases, and exopolysaccharide depolymerases, have been shown to be efficient against these struc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez, Diana, Fernández, Lucía, Martínez, Beatriz, Ruas-Madiedo, Patricia, García, Pilar, Rodríguez, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573737/
https://www.ncbi.nlm.nih.gov/pubmed/28883818
http://dx.doi.org/10.3389/fmicb.2017.01632
_version_ 1783259699629522944
author Gutiérrez, Diana
Fernández, Lucía
Martínez, Beatriz
Ruas-Madiedo, Patricia
García, Pilar
Rodríguez, Ana
author_facet Gutiérrez, Diana
Fernández, Lucía
Martínez, Beatriz
Ruas-Madiedo, Patricia
García, Pilar
Rodríguez, Ana
author_sort Gutiérrez, Diana
collection PubMed
description A current focus of research is the development of new tools for removing bacterial biofilms in industrial settings. Bacteriophage-encoded proteins, such as endolysins, virion-associated peptidoglycan hydrolases, and exopolysaccharide depolymerases, have been shown to be efficient against these structures. However, the current screening techniques for the identification of antibiofilm properties of phage-derived proteins have important shortcomings. The aim of this work was to use the rapid, reproducible and accurate technology “real-time cell analyzer” for screening and comparing the antibiofilm ability of four phage-derived compounds, three lytic proteins (LysH5, CHAP-SH3b, and HydH5-SH3b) and one exopolysaccharide depolymerase (Dpo7) against Staphylococcus aureus biofilms, which have been associated with recurrent contamination of food products. The data generated after biofilm treatment allowed for the calculation of different antibiofilm parameters: (1) the minimum biofilm eradicating concentration that removes 50% of the biofilm (ranging from 3.5 ± 1.1 to 6.6 ± 0.5 μM), (2) the lowest concentration needed to observe an antibiofilm effect (∼1.5 μM for all the proteins), and (3) the specific antibiofilm activity and the percentage of biofilm removal that revealed LysH5 as the best antibiofilm compound. Overall, this technology might be used to quickly assess and compare by standardized parameters the disaggregating activity of phage antibiofilm proteins.
format Online
Article
Text
id pubmed-5573737
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-55737372017-09-07 Real-Time Assessment of Staphylococcus aureus Biofilm Disruption by Phage-Derived Proteins Gutiérrez, Diana Fernández, Lucía Martínez, Beatriz Ruas-Madiedo, Patricia García, Pilar Rodríguez, Ana Front Microbiol Microbiology A current focus of research is the development of new tools for removing bacterial biofilms in industrial settings. Bacteriophage-encoded proteins, such as endolysins, virion-associated peptidoglycan hydrolases, and exopolysaccharide depolymerases, have been shown to be efficient against these structures. However, the current screening techniques for the identification of antibiofilm properties of phage-derived proteins have important shortcomings. The aim of this work was to use the rapid, reproducible and accurate technology “real-time cell analyzer” for screening and comparing the antibiofilm ability of four phage-derived compounds, three lytic proteins (LysH5, CHAP-SH3b, and HydH5-SH3b) and one exopolysaccharide depolymerase (Dpo7) against Staphylococcus aureus biofilms, which have been associated with recurrent contamination of food products. The data generated after biofilm treatment allowed for the calculation of different antibiofilm parameters: (1) the minimum biofilm eradicating concentration that removes 50% of the biofilm (ranging from 3.5 ± 1.1 to 6.6 ± 0.5 μM), (2) the lowest concentration needed to observe an antibiofilm effect (∼1.5 μM for all the proteins), and (3) the specific antibiofilm activity and the percentage of biofilm removal that revealed LysH5 as the best antibiofilm compound. Overall, this technology might be used to quickly assess and compare by standardized parameters the disaggregating activity of phage antibiofilm proteins. Frontiers Media S.A. 2017-08-24 /pmc/articles/PMC5573737/ /pubmed/28883818 http://dx.doi.org/10.3389/fmicb.2017.01632 Text en Copyright © 2017 Gutiérrez, Fernández, Martínez, Ruas-Madiedo, García and Rodríguez. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Gutiérrez, Diana
Fernández, Lucía
Martínez, Beatriz
Ruas-Madiedo, Patricia
García, Pilar
Rodríguez, Ana
Real-Time Assessment of Staphylococcus aureus Biofilm Disruption by Phage-Derived Proteins
title Real-Time Assessment of Staphylococcus aureus Biofilm Disruption by Phage-Derived Proteins
title_full Real-Time Assessment of Staphylococcus aureus Biofilm Disruption by Phage-Derived Proteins
title_fullStr Real-Time Assessment of Staphylococcus aureus Biofilm Disruption by Phage-Derived Proteins
title_full_unstemmed Real-Time Assessment of Staphylococcus aureus Biofilm Disruption by Phage-Derived Proteins
title_short Real-Time Assessment of Staphylococcus aureus Biofilm Disruption by Phage-Derived Proteins
title_sort real-time assessment of staphylococcus aureus biofilm disruption by phage-derived proteins
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573737/
https://www.ncbi.nlm.nih.gov/pubmed/28883818
http://dx.doi.org/10.3389/fmicb.2017.01632
work_keys_str_mv AT gutierrezdiana realtimeassessmentofstaphylococcusaureusbiofilmdisruptionbyphagederivedproteins
AT fernandezlucia realtimeassessmentofstaphylococcusaureusbiofilmdisruptionbyphagederivedproteins
AT martinezbeatriz realtimeassessmentofstaphylococcusaureusbiofilmdisruptionbyphagederivedproteins
AT ruasmadiedopatricia realtimeassessmentofstaphylococcusaureusbiofilmdisruptionbyphagederivedproteins
AT garciapilar realtimeassessmentofstaphylococcusaureusbiofilmdisruptionbyphagederivedproteins
AT rodriguezana realtimeassessmentofstaphylococcusaureusbiofilmdisruptionbyphagederivedproteins